Severe hypoglycemia secondary to methimazole‐induced insulin autoimmune syndrome in a 16 year old African‐American male
dc.contributor.author | Gomez Cruz, Michelle J. | en_US |
dc.contributor.author | Jabbar, Muhammad | en_US |
dc.contributor.author | Saini, Natinder | en_US |
dc.contributor.author | Eng, Donna | en_US |
dc.contributor.author | Crawford, Brandon | en_US |
dc.contributor.author | Vazquez, Delia M. | en_US |
dc.contributor.author | Menon, Ram | en_US |
dc.contributor.author | Chen, Ming | en_US |
dc.date.accessioned | 2012-12-11T17:37:26Z | |
dc.date.available | 2014-02-03T16:21:44Z | en_US |
dc.date.issued | 2012-12 | en_US |
dc.identifier.citation | Gomez Cruz, Michelle J.; Jabbar, Muhammad; Saini, Natinder; Eng, Donna; Crawford, Brandon; Vazquez, Delia M.; Menon, Ram; Chen, Ming (2012). "Severe hypoglycemia secondary to methimazole‐induced insulin autoimmune syndrome in a 16 year old African‐American male." Pediatric Diabetes 13(8): 652-655. <http://hdl.handle.net/2027.42/94489> | en_US |
dc.identifier.issn | 1399-543X | en_US |
dc.identifier.issn | 1399-5448 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/94489 | |
dc.description.abstract | Insulin autoimmune syndrome ( IAS ) or Hirata's disease is a rare disorder characterized by hypoglycemia secondary to insulin autoantibodies ( IAb ). Over 200 patients have been described from Japan with significantly less numbers being reported from outside the Orient. IAS is more common in patients older than 40 yr of age with reports in the pediatric age group being notably rarer. Exposure to sulfhydryl group containing medications is implicated in the pathogenesis of this syndrome. In this report, we describe a case of IAS in an African‐American adolescent. A 16‐yr‐old healthy African‐American male was diagnosed with Graves' disease and started on Methimazole. Four weeks later, he was found unconscious and hypoglycemic (blood sugar 1.5 mmol/L). Evaluation was negative for insulinoma. Insulin antibodies were positive. Oral glucose tolerance test revealed elevated free insulin concentrations with disproportionately elevated total insulin levels. The patient was started on prednisone, diazoxide, and propranolol for management of IAS and hyperthyroidism. Thyroid radio‐ablation was subsequently undertaken. The doses of prednisone and diazoxide were tapered and these medications discontinued after 9 months. The insulin antibody levels decreased gradually and became undetectable in 6 months with resolution of the hypoglycemia. | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Insulin Autoimmune Syndrome | en_US |
dc.subject.other | Graves' Disease | en_US |
dc.subject.other | Methimazole | en_US |
dc.subject.other | Hypoglycemia | en_US |
dc.title | Severe hypoglycemia secondary to methimazole‐induced insulin autoimmune syndrome in a 16 year old African‐American male | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 22759245 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/94489/1/pedi884.pdf | |
dc.identifier.doi | 10.1111/j.1399-5448.2012.00884.x | en_US |
dc.identifier.source | Pediatric Diabetes | en_US |
dc.identifier.citedreference | Uchigata Y, Eguchi Y et al. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract 1994: 22: 89 – 94. | en_US |
dc.identifier.citedreference | Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine 2009: 88: 141 – 153. | en_US |
dc.identifier.citedreference | Uchigata Y, Omori Y et al. HLA‐DR4 genotype and insulin‐processing in insulin autoimmune syndrome. Lancet 1992: 340: 1467. | en_US |
dc.identifier.citedreference | Ma WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc: JCMA 2005: 68: 82 – 86. | en_US |
dc.identifier.citedreference | Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne 1999: 150: 245 – 253. | en_US |
dc.identifier.citedreference | Loyd‐Mostyn RH, Oram S. Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 1975: 1: 1213 – 1215. | en_US |
dc.identifier.citedreference | Gallagher TF, Hellman L, Finkelstein J, Yoshida K, Weitzman ED, Roffwarg HD, Fukushima DK. Hyperthyroidism and cortisol secretion in man. J Clin Endocrinol Metab 1972: 34: 919 – 927. | en_US |
dc.identifier.citedreference | Bortolotti D, Mothe‐Satney I, Ferrari P, Gautier N, Sonke J, Pallé S, Bernard G, Badetti JL, Fredenrich A, Van Obberghen E, Canivet B. Spontaneous hypoglycemia in the presence of both anti‐insulin antibody and anti‐insulin receptor antibody. Diabetes Metab 2006: 32: 598 – 603. | en_US |
dc.identifier.citedreference | Redmon JB, Nuttall FQ. Autoimmune hypoglycemia. Endocr Metab Clin North Am 1999: 28: 603 – 618. | en_US |
dc.identifier.citedreference | Matsushita S, Takahashi K et al. (1994) Allele specificity of structural requirement for peptides bound to HLA‐DRB1*0405 and ‐DRB1*0406 complexes: implication for the HLA‐associated. J Exp Med 1994: 180: 873 – 883. | en_US |
dc.identifier.citedreference | Uchigata Y, Hirata Y, Iwamoto Y. Drug‐induced insulin autoimmune syndrome. Diabetes Res Clin Pract 2009: 83: e19 – e20. | en_US |
dc.identifier.citedreference | Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA‐DR4 alleles. Human Immunol 2000: 61: 154 – 157. | en_US |
dc.identifier.citedreference | Hirata Y, Uchigata Y. Insulin autoimmune syndrome. Nihon Rinsho Jpn J Clin Med 1997: 55: 786 – 791. | en_US |
dc.identifier.citedreference | Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract 1994: 24: S153 – S157. | en_US |
dc.identifier.citedreference | Uchigata Y, Kuwata S, Tsushima T, Tokunaga K, Miyamoto M, Tsuchikawa K, Hirata Y, Juji T, Omori Y. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA‐Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab 1993: 77: 249 – 254. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.